Nature Communications (Jan 2022)

Aberrant upregulation of the glycolytic enzyme PFKFB3 in CLN7 neuronal ceroid lipofuscinosis

  • Irene Lopez-Fabuel,
  • Marina Garcia-Macia,
  • Costantina Buondelmonte,
  • Olga Burmistrova,
  • Nicolo Bonora,
  • Paula Alonso-Batan,
  • Brenda Morant-Ferrando,
  • Carlos Vicente-Gutierrez,
  • Daniel Jimenez-Blasco,
  • Ruben Quintana-Cabrera,
  • Emilio Fernandez,
  • Jordi Llop,
  • Pedro Ramos-Cabrer,
  • Aseel Sharaireh,
  • Marta Guevara-Ferrer,
  • Lorna Fitzpatrick,
  • Christopher D. Thompton,
  • Tristan R. McKay,
  • Stephan Storch,
  • Diego L. Medina,
  • Sara E. Mole,
  • Peter O. Fedichev,
  • Angeles Almeida,
  • Juan P. Bolaños

DOI
https://doi.org/10.1038/s41467-022-28191-1
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 14

Abstract

Read online

CLN7 neuronal ceroid lipofuscinosis is an inherited lysosomal storage disease typically with childhood onset of neurodegenerative symptoms. Here the authors report that in a mouse model of CLN7 disease neuronal reactive oxygen species and the activity of glycolytic enzyme PFKFB3 are increased, while PFKFB3 inhibition ameliorates hallmarks of pathology.